JP2010528047A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010528047A5 JP2010528047A5 JP2010509554A JP2010509554A JP2010528047A5 JP 2010528047 A5 JP2010528047 A5 JP 2010528047A5 JP 2010509554 A JP2010509554 A JP 2010509554A JP 2010509554 A JP2010509554 A JP 2010509554A JP 2010528047 A5 JP2010528047 A5 JP 2010528047A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- factor
- antagonist
- amd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000005557 antagonist Substances 0.000 claims description 15
- 230000000295 complement effect Effects 0.000 claims description 15
- 206010064930 age-related macular degeneration Diseases 0.000 claims description 14
- 208000002780 macular degeneration Diseases 0.000 claims description 14
- 208000005590 Choroidal Neovascularization Diseases 0.000 claims description 10
- 206010060823 Choroidal neovascularisation Diseases 0.000 claims description 10
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 8
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 8
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 8
- 201000005667 central retinal vein occlusion Diseases 0.000 claims description 8
- 208000004644 retinal vein occlusion Diseases 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 206010055665 Corneal neovascularisation Diseases 0.000 claims description 4
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims description 4
- 201000002563 Histoplasmosis Diseases 0.000 claims description 4
- 208000007135 Retinal Neovascularization Diseases 0.000 claims description 4
- 208000017442 Retinal disease Diseases 0.000 claims description 4
- 206010038923 Retinopathy Diseases 0.000 claims description 4
- 206010046851 Uveitis Diseases 0.000 claims description 4
- 201000000159 corneal neovascularization Diseases 0.000 claims description 4
- 208000001309 degenerative myopia Diseases 0.000 claims description 4
- 230000004340 degenerative myopia Effects 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 201000011190 diabetic macular edema Diseases 0.000 claims description 4
- 208000028867 ischemia Diseases 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 208000006542 von Hippel-Lindau disease Diseases 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 2
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 208000011325 dry age related macular degeneration Diseases 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 17
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93979107P | 2007-05-23 | 2007-05-23 | |
| US60/939,791 | 2007-05-23 | ||
| PCT/US2008/064526 WO2008147883A1 (en) | 2007-05-23 | 2008-05-22 | Prevention and treatment of complement-associated eye conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013236445A Division JP2014087346A (ja) | 2007-05-23 | 2013-11-15 | 補体が関係している眼の状態の予防および治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010528047A JP2010528047A (ja) | 2010-08-19 |
| JP2010528047A5 true JP2010528047A5 (OSRAM) | 2012-05-10 |
| JP5416695B2 JP5416695B2 (ja) | 2014-02-12 |
Family
ID=39638868
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509554A Expired - Fee Related JP5416695B2 (ja) | 2007-05-23 | 2008-05-22 | 補体が関係している眼の状態の予防および治療 |
| JP2013236445A Withdrawn JP2014087346A (ja) | 2007-05-23 | 2013-11-15 | 補体が関係している眼の状態の予防および治療 |
| JP2016015288A Withdrawn JP2016145205A (ja) | 2007-05-23 | 2016-01-29 | 補体が関係している眼の状態の予防および治療 |
| JP2017146477A Pending JP2017197577A (ja) | 2007-05-23 | 2017-07-28 | 補体が関係している眼の状態の予防および治療 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013236445A Withdrawn JP2014087346A (ja) | 2007-05-23 | 2013-11-15 | 補体が関係している眼の状態の予防および治療 |
| JP2016015288A Withdrawn JP2016145205A (ja) | 2007-05-23 | 2016-01-29 | 補体が関係している眼の状態の予防および治療 |
| JP2017146477A Pending JP2017197577A (ja) | 2007-05-23 | 2017-07-28 | 補体が関係している眼の状態の予防および治療 |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US8007791B2 (OSRAM) |
| EP (1) | EP2152755B1 (OSRAM) |
| JP (4) | JP5416695B2 (OSRAM) |
| KR (1) | KR101540126B1 (OSRAM) |
| CN (3) | CN104367999A (OSRAM) |
| AR (1) | AR066660A1 (OSRAM) |
| AU (1) | AU2008256835B2 (OSRAM) |
| BR (1) | BRPI0811142A8 (OSRAM) |
| CA (1) | CA2683498A1 (OSRAM) |
| CL (1) | CL2008001498A1 (OSRAM) |
| CY (1) | CY1116062T1 (OSRAM) |
| DK (1) | DK2152755T3 (OSRAM) |
| ES (1) | ES2533242T3 (OSRAM) |
| HK (1) | HK1207327A1 (OSRAM) |
| HR (1) | HRP20150281T1 (OSRAM) |
| IL (2) | IL201476A (OSRAM) |
| MX (1) | MX2009012422A (OSRAM) |
| PE (1) | PE20090294A1 (OSRAM) |
| PH (1) | PH12013500992B1 (OSRAM) |
| PL (1) | PL2152755T3 (OSRAM) |
| PT (1) | PT2152755E (OSRAM) |
| RS (1) | RS53901B1 (OSRAM) |
| RU (2) | RU2522976C2 (OSRAM) |
| SG (1) | SG10201401404RA (OSRAM) |
| SI (1) | SI2152755T1 (OSRAM) |
| TW (2) | TW201417829A (OSRAM) |
| WO (1) | WO2008147883A1 (OSRAM) |
| ZA (1) | ZA200907028B (OSRAM) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2026073B1 (en) * | 2000-04-29 | 2016-03-30 | University Of Iowa Research Foundation | Diagnostics and therapeutics for macular degeneration-related disorders |
| ES2551202T5 (es) * | 2005-11-04 | 2018-11-30 | Genentech, Inc. | Uso de inhibidores de la vía del complemento para tratar enfermedades oculares |
| CN106084054A (zh) | 2006-11-02 | 2016-11-09 | 健泰科生物技术公司 | 人源化的抗‑d因子抗体 |
| AR066660A1 (es) * | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| CR20170001A (es) | 2008-04-28 | 2017-08-10 | Genentech Inc | Anticuerpos anti factor d humanizados |
| MX2011002367A (es) * | 2008-09-02 | 2011-04-04 | Novartis Ag | Inhibidores de cinasa biciclicos. |
| US8623395B2 (en) | 2010-01-29 | 2014-01-07 | Forsight Vision4, Inc. | Implantable therapeutic device |
| CA3045436C (en) | 2009-01-29 | 2025-10-07 | Forsight Vision4 Inc | Posterior segment drug delivery |
| US9309325B2 (en) | 2009-05-07 | 2016-04-12 | The Regents Of The University Of California | Antibodies and methods of use thereof |
| US20110165648A1 (en) | 2009-11-04 | 2011-07-07 | Menno Van Lookeren Campagne | Co-crystal structure of factor D and anti-factor D antibody |
| HUE057267T2 (hu) * | 2010-08-05 | 2022-05-28 | Forsight Vision4 Inc | Berendezés szem kezelésére |
| PL2635704T3 (pl) * | 2010-11-01 | 2017-09-29 | F.Hoffmann-La Roche Ag | Przewidywanie progresji do zaawansowanego zwyrodnienia plamki żółtej związanego z wiekiem z zastosowaniem wskaźnika poligenicznego |
| WO2012093101A1 (en) | 2011-01-04 | 2012-07-12 | Novartis Ag | Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| AR085091A1 (es) | 2011-01-26 | 2013-09-11 | Kolltan Pharmaceuticals Inc | Anticuerpos anti-kit y sus usos |
| JP6273274B2 (ja) | 2012-06-28 | 2018-01-31 | ノバルティス アーゲー | 補体経路モジュレーターおよびその使用 |
| JP6155332B2 (ja) | 2012-06-28 | 2017-06-28 | ノバルティス アーゲー | ピロリジン誘導体、および補体経路調節因子としてのその使用 |
| WO2014002052A1 (en) | 2012-06-28 | 2014-01-03 | Novartis Ag | Pyrrolidine derivatives and their use as complement pathway modulators |
| ES2712190T3 (es) | 2012-06-28 | 2019-05-09 | Novartis Ag | Moduladores de la vía del complemento y sus usos |
| JP6209605B2 (ja) | 2012-06-28 | 2017-10-04 | ノバルティス アーゲー | ピロリジン誘導体、および補体経路調節因子としてのその使用 |
| EA201590200A1 (ru) | 2012-07-12 | 2015-08-31 | Новартис Аг | Модуляторы пути активации комплемента и их применение |
| SG11201500489YA (en) | 2012-07-25 | 2015-02-27 | Kolltan Pharmaceuticals Inc | Anti-kit antibodies and uses thereof |
| WO2014120555A1 (en) | 2013-01-31 | 2014-08-07 | The Regents Of The University Of California | Antibodies specific for urokinase-type plasminogen activator and methods of use thereof |
| ES2972168T3 (es) | 2013-03-28 | 2024-06-11 | Forsight Vision4 Inc | Implante oftálmico para administración de sustancias terapéuticas |
| CR20160132A (es) | 2013-08-12 | 2016-08-25 | Genentech Inc | Composiciones y método para tratar condiciones asociadas con el complemento |
| EP3054965B1 (en) * | 2013-10-07 | 2021-04-14 | Massachusetts Eye & Ear Infirmary | Anti-factor d antibody for use in preventing or reducing retinal detachment |
| AU2014339890A1 (en) * | 2013-10-25 | 2016-06-02 | Children's Medical Center Corporation | Methods of treating or preventing vascular diseases of the retina |
| SG11201608868PA (en) * | 2014-05-01 | 2016-11-29 | Genentech Inc | Anti-factor d antibody variants and uses thereof |
| CN106659782B (zh) | 2014-05-23 | 2021-11-09 | 塞尔德克斯医疗公司 | 一种用于嗜酸性粒细胞或肥大细胞相关病症治疗的抗体 |
| SI3352776T1 (sl) * | 2015-09-23 | 2025-08-29 | Sangamo Therapeutics, Inc. | Represorji Htt in njihove uporabe |
| EP3368074A2 (en) | 2015-10-30 | 2018-09-05 | Hoffmann-La Roche AG | Anti-factor d antibodies and conjugates |
| EP3368682B1 (en) | 2015-10-30 | 2019-12-11 | H. Hoffnabb-La Roche Ag | Methods of measuring factor d activity and potency of factor d inhibitors |
| EP3368090A1 (en) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Anti-factor d antibody variant conjugates and uses thereof |
| SI3368578T1 (sl) | 2015-10-30 | 2021-08-31 | F. Hoffmann-La Roche Ag | Protitelesa proti HtrA1 in postopki uporabe |
| HUE056019T2 (hu) * | 2015-12-23 | 2022-01-28 | eleva GmbH | Polipeptidek komplement aktiváció gátlására |
| CN108934169A (zh) * | 2016-01-20 | 2018-12-04 | 维特里萨医疗公司 | 用于抑制因子d的组合物和方法 |
| WO2018136827A1 (en) | 2017-01-20 | 2018-07-26 | Vitrisa Therapeutics, Inc. | Stem-loop compositions and methods for inhibiting factor d |
| CA3053155A1 (en) * | 2017-02-10 | 2018-08-16 | The Trustees Of The University Of Pennsylvania | Anti-factor d antibodies and uses thereof |
| CN109632924B (zh) * | 2018-12-17 | 2022-02-08 | 上海市第一人民医院 | 人黄斑新生血管性疾病的血浆脂质标记物及其应用 |
| WO2021009777A2 (en) * | 2019-07-18 | 2021-01-21 | Pandorum Technologies Private Limited | Methods of stem cell culture for obtaining products, and implementations thereof |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6620915B2 (en) * | 1993-12-23 | 2003-09-16 | Icos Corporation | Monoclonal antibodies specific for integrin α-d subunit |
| WO2002000690A2 (en) | 2000-06-23 | 2002-01-03 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| WO2002008284A2 (en) | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| WO1999040100A1 (en) * | 1998-02-09 | 1999-08-12 | Human Genome Sciences, Inc. | 45 human secreted proteins |
| US20050197285A1 (en) * | 1997-03-07 | 2005-09-08 | Rosen Craig A. | Human secreted proteins |
| US6472520B2 (en) * | 1997-03-21 | 2002-10-29 | The Trustees Of Columbia University In The City Of New York | Rat PEG-3 promoter |
| US6410708B1 (en) | 1997-11-21 | 2002-06-25 | Genentech, Inc. | Nucleic acids encoding A-33 related antigen polypeptides |
| US7419663B2 (en) * | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
| US7282565B2 (en) * | 1998-03-20 | 2007-10-16 | Genentech, Inc. | PRO362 polypeptides |
| US7192589B2 (en) * | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
| US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| ES2305608T3 (es) | 1997-11-21 | 2008-11-01 | Genentech, Inc. | Antigenos tipo a-33 y sus utilizaciones farmacologicas. |
| US8007798B2 (en) * | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| DE69939813D1 (de) * | 1998-02-20 | 2008-12-11 | Tanox Inc | Inhibitoren der komplement-aktivierung |
| US6956107B2 (en) | 1998-02-20 | 2005-10-18 | Tanox, Inc. | Inhibitors of complement activation |
| DK1490386T3 (da) | 1998-03-10 | 2008-12-15 | Genentech Inc | Nyt polypeptid og nukleinsyrer kodende for dette |
| CA2340794A1 (en) | 1998-08-27 | 2000-03-09 | Incyte Pharmaceuticals, Inc. | Protein transport-associated molecules |
| CA2348757A1 (en) | 1998-12-16 | 2000-06-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| DE69930872T8 (de) * | 1998-12-21 | 2007-05-03 | Ludwig Institute For Cancer Research | Antikörper gegen verkürzten vegf-d und deren verwendungen |
| JP3993746B2 (ja) | 1998-12-22 | 2007-10-17 | ジェネンテック・インコーポレーテッド | 腫瘍性細胞成長阻害のための組成物及び方法 |
| KR20010103046A (ko) | 1999-03-08 | 2001-11-17 | 제넨테크, 인크. | 면역 관련 질환 치료용 조성물 및 치료 방법 |
| CN1637019A (zh) | 1999-03-11 | 2005-07-13 | Rmf迪克塔吉恩有限公司 | 血管粘着分子及其功能的调节 |
| US6642353B1 (en) * | 1999-03-17 | 2003-11-04 | Chugai Seiyaku Kabushiki Kaisha | Peptide ligands for the erythropoietin receptor |
| AU2883900A (en) | 1999-07-07 | 2001-01-30 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| UA72943C2 (uk) | 1999-11-02 | 2005-05-16 | Ульяновскій Государствєнний Тєхніческій Унівєрсітєт | Спосіб очищення рідини від феромагнітних частинок (варіанти) і пристрій для його здійснення (варіанти) |
| AU1604401A (en) | 1999-11-19 | 2001-05-30 | Human Genome Sciences, Inc. | 18 human secreted proteins |
| EP1686134A3 (en) | 1999-12-01 | 2006-08-09 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US20040152105A1 (en) * | 2002-09-06 | 2004-08-05 | Cytos Biotechnology Ag. | Immune modulatory compounds and methods |
| RU2232991C1 (ru) * | 2003-04-09 | 2004-07-20 | Государственное учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" | Способ определения функциональной активности фактора d комплемента человека |
| WO2006071856A2 (en) | 2004-12-23 | 2006-07-06 | Glycofi, Inc. | Immunoglobulins comprising predominantly a man5glcnac2 glycoform |
| ES2551202T5 (es) * | 2005-11-04 | 2018-11-30 | Genentech, Inc. | Uso de inhibidores de la vía del complemento para tratar enfermedades oculares |
| US20070190057A1 (en) | 2006-01-23 | 2007-08-16 | Jian Wu | Methods for modulating mannose content of recombinant proteins |
| CN106084054A (zh) * | 2006-11-02 | 2016-11-09 | 健泰科生物技术公司 | 人源化的抗‑d因子抗体 |
| AR066660A1 (es) * | 2007-05-23 | 2009-09-02 | Genentech Inc | Prevencion y tratamiento de condiciones del ojo asociadas con su complemento |
| JP4349447B2 (ja) | 2007-07-19 | 2009-10-21 | トヨタ自動車株式会社 | インバータ制御装置および車両 |
-
2008
- 2008-05-21 AR ARP080102150A patent/AR066660A1/es unknown
- 2008-05-22 CN CN201410486706.3A patent/CN104367999A/zh active Pending
- 2008-05-22 AU AU2008256835A patent/AU2008256835B2/en not_active Ceased
- 2008-05-22 EP EP08756130.4A patent/EP2152755B1/en active Active
- 2008-05-22 PT PT87561304T patent/PT2152755E/pt unknown
- 2008-05-22 SG SG10201401404RA patent/SG10201401404RA/en unknown
- 2008-05-22 CA CA002683498A patent/CA2683498A1/en not_active Abandoned
- 2008-05-22 ES ES08756130.4T patent/ES2533242T3/es active Active
- 2008-05-22 DK DK08756130.4T patent/DK2152755T3/en active
- 2008-05-22 WO PCT/US2008/064526 patent/WO2008147883A1/en not_active Ceased
- 2008-05-22 CN CN201610972614.5A patent/CN107096029B/zh not_active Expired - Fee Related
- 2008-05-22 JP JP2010509554A patent/JP5416695B2/ja not_active Expired - Fee Related
- 2008-05-22 CN CN200880100137.7A patent/CN101754980B/zh not_active Expired - Fee Related
- 2008-05-22 RS RS20150223A patent/RS53901B1/sr unknown
- 2008-05-22 SI SI200831405T patent/SI2152755T1/sl unknown
- 2008-05-22 BR BRPI0811142A patent/BRPI0811142A8/pt not_active Application Discontinuation
- 2008-05-22 RU RU2009147744/10A patent/RU2522976C2/ru not_active IP Right Cessation
- 2008-05-22 PL PL08756130T patent/PL2152755T3/pl unknown
- 2008-05-22 HR HRP20150281AT patent/HRP20150281T1/hr unknown
- 2008-05-22 MX MX2009012422A patent/MX2009012422A/es active IP Right Grant
- 2008-05-22 KR KR1020097026746A patent/KR101540126B1/ko not_active Expired - Fee Related
- 2008-05-22 US US12/154,466 patent/US8007791B2/en not_active Expired - Fee Related
- 2008-05-23 TW TW102134844A patent/TW201417829A/zh unknown
- 2008-05-23 TW TW097119194A patent/TWI419704B/zh not_active IP Right Cessation
- 2008-05-23 PE PE2008000887A patent/PE20090294A1/es not_active Application Discontinuation
- 2008-05-23 CL CL2008001498A patent/CL2008001498A1/es unknown
-
2009
- 2009-10-08 ZA ZA2009/07028A patent/ZA200907028B/en unknown
- 2009-10-13 IL IL201476A patent/IL201476A/en active IP Right Grant
-
2011
- 2011-07-22 US US13/189,301 patent/US8268310B2/en not_active Expired - Fee Related
-
2012
- 2012-07-20 US US13/554,787 patent/US8497094B2/en not_active Expired - Fee Related
-
2013
- 2013-05-16 PH PH12013500992A patent/PH12013500992B1/en unknown
- 2013-06-27 US US13/929,167 patent/US20130302333A1/en not_active Abandoned
- 2013-11-15 JP JP2013236445A patent/JP2014087346A/ja not_active Withdrawn
-
2014
- 2014-04-03 RU RU2014113046/10A patent/RU2014113046A/ru not_active Application Discontinuation
-
2015
- 2015-02-27 CY CY20151100205T patent/CY1116062T1/el unknown
- 2015-08-14 HK HK15107851.6A patent/HK1207327A1/xx unknown
-
2016
- 2016-01-29 JP JP2016015288A patent/JP2016145205A/ja not_active Withdrawn
- 2016-02-03 US US15/014,886 patent/US20160272726A1/en not_active Abandoned
- 2016-10-27 IL IL248552A patent/IL248552A0/en unknown
-
2017
- 2017-07-28 JP JP2017146477A patent/JP2017197577A/ja active Pending
- 2017-11-29 US US15/826,016 patent/US20180079826A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010528047A5 (OSRAM) | ||
| RU2014113046A (ru) | Профилактика и лечение патологических состояний глаз, вызванных комплементом | |
| WO2008154251A4 (en) | C3b antibodies and methods for the prevention and treatment of complement- associated disorders | |
| JP2011504872A5 (OSRAM) | ||
| JP5990511B2 (ja) | 血管新生に基づく眼障害の処置のための抗ｃｄ１６０特異的抗体 | |
| JP2016504416A5 (OSRAM) | ||
| US20220162296A1 (en) | Personalized treatment of ophthalmologic diseases | |
| JP2020535184A5 (OSRAM) | ||
| RU2008144802A (ru) | Применение антител против ил-1 для лечения глазных расстройств | |
| RU2015121755A (ru) | Антагонисты ил-6 и их применение | |
| JP2017535285A5 (OSRAM) | ||
| JP2014532072A5 (OSRAM) | ||
| JP2015503909A5 (OSRAM) | ||
| WO2009040336A1 (en) | Antigen binding proteins | |
| JP2011503094A5 (OSRAM) | ||
| JP2017502023A (ja) | 眼疾患を治療する組成物および方法 | |
| JP2018530574A5 (OSRAM) | ||
| RU2018103960A (ru) | Антитела против ang-2, содержащие только тяжелую цепь | |
| JP2018527327A5 (OSRAM) | ||
| JP2025114621A (ja) | 神経変性疾患を治療するための改変抗ｐｄ－ｌ１抗体および治療方法および使用 | |
| JP2018523673A5 (OSRAM) | ||
| JP7382343B2 (ja) | Ｍｆａｐ４に対する抗体 | |
| JP2021513360A5 (OSRAM) | ||
| JP2020518641A5 (OSRAM) | ||
| RU2022102753A (ru) | Fab ФРАГМЕНТ ГУМАНИЗИРОВАННОГО АНТИТЕЛА ПРОТИВ VEGF И ЕГО ПРИМЕНЕНИЕ |